Meningococcal Disease: Methods and Proto
β Andrew J. Pollard and Martin C.J. Maiden
π Library
π
2001
π English
β¦ LIBER β¦
π
Meningococcal Disease: Methods and Protocols
β Scribed by Keith Cartwright (auth.), John M. Walker, Andrew J. Pollard MD, PhD, Martin C. J. Maiden PhD (eds.)
- Publisher
- Humana Press
- Year
- 2001
- Tongue
- English
- Leaves
- 714
- Series
- Methods in Molecular Medicineβ’ 67
- Edition
- 1
- Category
- Library
β¬ Acquire This Volume
No coin nor oath required. For personal study only.
β¦ Synopsis
Neisseria meningitidis is a major cause of childhood morbidity and mortality in industrialized nations and is responsible for epidemics of meningococcal meningitis and septic shock in Africa and Asia. In Meningococcal Disease: Methods and Protocols, Andrew Pollard and Martin Maiden bring together a panel of leading authorities to produce a comprehensive, interdisciplinary survey of recent advances and knowledge about this much-feared disease. The review and methods-based chapters collected here provide essential information for diagnosis in the clinical microbiology laboratory, isolate characterization, clinical management, and control of meningococcal disease. They also examine the immunopathological mechanisms occurring in the acutely ill, host-pathogen interactions, and the possible components of meningococcus responsible for virulence. A companion volume, Meningococcal Vaccines, provides detailed methods for the design and evaluation of meningococcal vaccines.
Comprehensive and authoritative, Meningococcal Disease: Methods and Protocols integrates the basic science and the clinical and epidemiological aspects of this terrible infectious disease to promote the deeper understanding needed to identify novel targets for therapeutic interventions and vaccines.
β¦ Table of Contents
Front Matter....Pages i-xvii
Back Matter....Pages 1-8
....Pages 9-21
β¦ Subjects
Infectious Diseases
π SIMILAR VOLUMES
Meningococcal Vaccines: Methods and Prot
β Ian M. Feavers (auth.), Andrew J. Pollard MD, PhD, Martin C.J. Maiden PhD (eds.)
π Library
π
2001
π Humana Press
π English
<p>The development of a comprehensive vaccine against Neisseria meningitidis, the causative agent of meningococcal disease, has remained elusive because of bacterial diversity and immunologic evasion. In Meningococcal Vaccines: Methods and Protocols, Andrew Pollard and Martin Maiden have assembled a
Meningococcal Vaccines: Methods and Prot
β Andrew J. Pollard, Martin C.J. Maiden
π Library
π
2001
π Humana Press
π English
Andrew Pollard and Martin Maiden have assembled an impressive collection of the latest molecular and cellular techniques for the development, evaluation, and implementation of vaccines to be used against this dreaded disease. The contributors-leading scientists, clinicians, and public health physici
Meningococcal Vaccines: Methods and Prot
β Ian M. Feavers (auth.), Andrew J. Pollard MD, PhD, Martin C.J. Maiden PhD (eds.)
π Library
π
2001
π Humana Press
π English
<p>The development of a comprehensive vaccine against Neisseria meningitidis, the causative agent of meningococcal disease, has remained elusive because of bacterial diversity and immunologic evasion. In Meningococcal Vaccines: Methods and Protocols, Andrew Pollard and Martin Maiden have assembled a
Meningococcal Vaccines. Methods and Prot
β Andrew J. Pollard, Martin C.J. Maiden
π Library
π
2001
π Humana Press
π English
Andrew Pollard and Martin Maiden have assembled an impressive collection of the latest molecular and cellular techniques for the development, evaluation, and implementation of vaccines to be used against this dreaded disease. The contributors-leading scientists, clinicians, and public health physici
Meningococcal Vaccines: Methods and Prot
β Andrew J. Pollard, Martin C.J. Maiden
π Library
π
2001
π English
Andrew Pollard and Martin Maiden have assembled an impressive collection of the latest molecular and cellular techniques for the development, evaluation, and implementation of vaccines to be used against this dreaded disease. The contributors-leading scientists, clinicians, and public health physici